Safe Orthopaedics SA (ALSAF) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.098x

Based on the latest financial reports, Safe Orthopaedics SA (ALSAF) has a cash flow conversion efficiency ratio of 0.098x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-1.53 Million ≈ $-1.79 Million USD) by net assets (€-15.70 Million ≈ $-18.36 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see ALSAF market cap for the company's overall valuation and market capitalisation.

Safe Orthopaedics SA - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Safe Orthopaedics SA's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Safe Orthopaedics SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Safe Orthopaedics SA ranked by their cash flow conversion efficiency. See ALSAF cash flow to debt ratio to evaluate how effectively operating cash flow covers total debt obligations.

Company Cash Flow Conversion Efficiency
Thruvision Group PLC
LSE:THRU
-0.076x
SCANDIN.ENVIRO SYSTEMS AB
F:1HR
-0.151x
Tavistock Investments Plc
LSE:TAVI
-0.096x
Matahari Department Store Tbk
JK:LPPF
0.688x
The Investment Company plc
LSE:INV
-0.009x
Xeros Technology Group Plc
LSE:XSG
-1.072x
Oxurion NV
BR:OXUR
0.097x
Sumo Resources PLC
PA:MLSUM
N/A

Annual Cash Flow Conversion Efficiency for Safe Orthopaedics SA (2012–2025)

The table below shows the annual cash flow conversion efficiency of Safe Orthopaedics SA from 2012 to 2025. View ALSAF stock price and chart for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 €-10.68 Million
≈ $-12.49 Million
€-2.01 Million
≈ $-2.35 Million
0.188x -51.41%
2024-12-31 €-8.42 Million
≈ $-9.85 Million
€-3.27 Million
≈ $-3.82 Million
0.388x +6809.83%
2023-12-31 €-202.35 Million
≈ $-236.57 Million
€-1.14 Million
≈ $-1.33 Million
0.006x -99.87%
2022-12-31 €-1.28 Million
≈ $-1.50 Million
€-5.47 Million
≈ $-6.40 Million
4.277x +127.20%
2021-12-31 €398.00K
≈ $465.30K
€-6.26 Million
≈ $-7.32 Million
-15.726x +37.73%
2020-12-31 €237.00K
≈ $277.08K
€-5.99 Million
≈ $-7.00 Million
-25.253x -2243.74%
2019-12-31 €-4.28 Million
≈ $-5.00 Million
€-5.04 Million
≈ $-5.90 Million
1.178x +122.61%
2018-12-31 €1.19 Million
≈ $1.39 Million
€-6.21 Million
≈ $-7.27 Million
-5.210x -11.80%
2017-12-31 €1.06 Million
≈ $1.24 Million
€-4.93 Million
≈ $-5.76 Million
-4.660x +70.49%
2016-12-31 €367.00K
≈ $429.06K
€-5.80 Million
≈ $-6.78 Million
-15.793x -1137.00%
2015-12-31 €5.09 Million
≈ $5.95 Million
€-6.50 Million
≈ $-7.60 Million
-1.277x +37.81%
2014-12-31 €2.46 Million
≈ $2.88 Million
€-5.05 Million
≈ $-5.91 Million
-2.053x -111.11%
2013-12-31 €-194.00K
≈ $-226.81K
€-3.58 Million
≈ $-4.19 Million
18.479x +960.95%
2012-12-31 €1.17 Million
≈ $1.37 Million
€-2.51 Million
≈ $-2.93 Million
-2.146x --

About Safe Orthopaedics SA

PA:ALSAF France Medical Instruments & Supplies
Market Cap
$149.08K
€127.51K EUR
Market Cap Rank
#31435 Global
#595 in France
Share Price
€0.64
Change (1 day)
+0.00%
52-Week Range
€0.55 - €2.40
All Time High
€1000000.00
About

Safe Orthopaedics SA, a medical technology company, develops and markets ready-to-use implants and sterile instrumentation for spinal surgery in France. It offers SteriSpine PS, an all-round kit for open, mini open, and MIS surgeries, as well as percutaneous kit; SteriSpine VA, a product platform for ready to use Kyphoplasty and Cement systems; SteriSpine LC, a ready to use instrumentation for lu… Read more